News
Cantor Fitzgerald Reiterates Overweight on Skye Bioscience, Maintains $14 Price Target
17 Jun 24
News, Price Target, Reiteration, Analyst Ratings
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
10 Jun 24
12 Health Care Stocks Moving In Monday's Intraday Session
10 Jun 24
Movers
Market-Moving News for June 10th
10 Jun 24
Movers, Trading Ideas
Perion Network Cuts Revenue Outlook, Joins Skye Bioscience And Other Big Stocks Moving Lower In Monday's Pre-Market Session
10 Jun 24
Earnings, News, Guidance, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Monday's Pre-Market Session
10 Jun 24
Movers
Cantor Fitzgerald Initiates Coverage On Skye Bioscience with Overweight Rating, Announces Price Target of $21
23 May 24
News, Price Target, Initiation, Analyst Ratings
12 Health Care Stocks Moving In Thursday's Pre-Market Session
2 May 24
Movers
Oppenheimer Initiates Coverage On Skye Bioscience with Outperform Rating, Announces Price Target of $25
12 Apr 24
News, Price Target, Initiation, Analyst Ratings
Press releases
Skye Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program
10 Jun 24
Press Releases
Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting
10 May 24
Press Releases
Skye Bioscience Moves to Nasdaq, Hits Milestone in Clinical Program
7 May 24